Carmustine 100 mg per vial for injection, contains carmusting as the active ingredients. Carmustine belongs to a group of anticancer medicine know as nitrosourea that act by slowing of cancer growth.
Carmusting is effective in the following malignant neoplasms as a single agent or in combination with other antineoplastics and/or other therapeutic measures (radiotherapy/surgery)
Brain tumors (glioblastoma, brain stem glioma, medulloblastoma, astrocytoma and ependymoma), brain metastasis.
Secondary therapy in non-Hodgkin’s lymphoma and Hodgkin disease.
BEAM protocol as a conditioning treatment prior to autologous hematopoietic stem cell transplantation (auto-HSCT).